Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02674464
Other study ID # IRB00085630
Secondary ID UH3HL130688
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date February 28, 2022

Study information

Verified date June 2022
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The RICH LIFE Project is a two-armed, cluster-randomized trial, comparing the effectiveness of an enhanced standard of care arm, "Standard of Care Plus" (SCP), to a multi-level intervention, "Collaborative Care/Stepped Care" (CC/SC), in improving blood pressure control, patient activation and reducing disparities in blood pressure control among 1,890 adult patients with uncontrolled hypertension and cardiovascular disease risk factors at thirty primary care practices in Maryland and Pennsylvania. Fifteen practices randomized to the SCP arm receive standardized blood pressure measurement training, and audit and feedback of blood pressure control rates at the practice provider level. Fifteen practices in the CC/SC arm receive all the SCP interventions plus the implementation of the collaborative care model with additional stepped-care components of community health worker referrals and subspecialist curbside consults and an on-going virtual workshop for organizational leaders in quality improvement and disparities reduction. The primary clinical outcomes are the percent of patients with blood pressure <140/90 mm Hg and change from baseline in mean systolic blood pressure at 12 months. The primary patient reported outcome is change from baseline in self-reported patient activation at 12 months.


Description:

The investigators refined research aim is to determine if a clinic-based collaborative care team, including a community health worker (CHW) to deliver community-based contextualized care, reduces disparities in blood pressure control rates, lowers cardiovascular disease (CVD) risk, and improves outcomes among patients with hypertension and other common comorbid conditions when compared to standard of care health system approaches to CVD risk management, including audit and feedback and staff and provider training. Collaborative care includes care coordination and care management; regular and proactive monitoring and treatment to target specific patient needs using validated clinical tools and rating scales; and regular systematic caseload reviews by the care team and consultation with experts for patients who do not show clinical improvement. A typical collaborative care team includes the primary care provider, nurse care manager or coordinator, and other members of the clinic staff involved in patient care. Intervention protocols are designed to address common comorbidities (diabetes, hyperlipidemia, depression and coronary heart disease), lifestyle factors (dietary intake, physical activity, and smoking) and medication adherence. The intensive intervention treats the "whole" patient, driven by individual patient goals and priorities, as opposed to the standard of care, which typically focuses on individual conditions. This proposed study responds directly to patient desires to feel more equipped to be involved in their care and manage multiple conditions that contribute to CVD. The investigators have worked successfully in the past with a broad range of stakeholders, including community members, patients, providers, and payors, and will continue to engage them through the research and dissemination process.


Recruitment information / eligibility

Status Completed
Enrollment 1820
Est. completion date February 28, 2022
Est. primary completion date February 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 100 Years
Eligibility Inclusion Criteria: 1. Adult patients (=21 years of age) obtaining primary care from a provider at a participating practice 2. A diagnosis of hypertension or SBP=140mmHg or DBP=90mmHg twice in the past year or on antihypertensive medications plus at least one of the following CVD risk factors: - Diabetes mellitus (fasting blood sugar> 125mg/dl or hemoglobin A1c>6.5 or on a hypoglycemic medication); - Dyslipidemia (LDL >130 mg/dl, HDL<40 or total cholesterol >200 or on a lipid lowering agent); - Coronary heart disease - Current tobacco smokers - Depression by International Classification of Disease, 9th edition (ICD-9), codes or Patient Health Questionnaire (PHQ) score >9 Exclusion Criteria: 1. Cardiovascular event (unstable angina, myocardial infarction) within the past 6 months 2. Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers) 3. Condition which interferes with outcome measurement (e.g., dialysis) 4. Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician. 5. Alcohol or substance use disorder if not sober/abstinent for =30 days 6. Planning to leave clinic within 6 months or move out of geographic area within 18 months 7. Individuals with cognitive impairment or other condition which makes them unable to participate in the intervention 8. Participating in another lifestyle modification, weight reduction, or treatment trial

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Provider Audit-Feedback, Stratified by Race and Ethnicity
Transparent and timely access to and review of clinical performance data are among the key elements of successful improvement activities. The RICH LIFE Project provides the health systems with the logic to build practice and provider level hypertension (HTN) dashboards, support in building the dashboard, and education in utilizing the dashboard. The practice dashboard provides a display of the percentage of patients achieving BP control, defined as <140/90 mm Hg for the overall practice, while the provider dashboard provides a display of the percentage of patients achieving BP control for each provider's patient panel. Both the practice and provider Dashboards stratify hypertension performance data by race (White, non-Hispanic; Black, non-Hispanic; and All Hispanic) to help practice administration and clinicians evaluate differences between races and ethnicities in BP control rates. New reports are generated at least quarterly and will display data from the previous 3 months.
Blood Pressure Measurement Standardization
All adult medicine staff at participating study practices receive standardized, evidence-based, best practices BP measurement training. Aspects of the training include proper patient preparation and positioning, how use of an automated BP measurement device, and executing a "screen and confirm" protocol when measuring patients' blood pressures.
System Level Leadership Intervention
This System-Level Leadership intervention aims to create a learning network through an inter-organizational approach to promote health equity and reduce CVD disparities. Elements of the system-level leadership intervention, then, include: 1) an introductory session during the kick-off event (baseline); 2) a quarterly 1 hour "content call" with a presentation on leading for equity and discussion among system-level leaders, community organization leaders, and interested practice champions in the CC/Stepped care arm conducted via conference call/webinar; and 3) monthly "coaching calls" for the system and practice level leaders, CMs, and CHWs in the CC/stepped care arm to discuss the interventions, while they are actively engaged in the intervention phase.
Collaborative Care Team Intervention
The collaborative care intervention creates a collaborative care team that, at a minimum, consists of PCP, nurse, or social worker care manager, and community health worker. The collaborative care team develops the medical management plan in partnership with patients; 2) uses care coordination to maximize interaction of the patients' PCPs with other care providers addressing medication management, patient self-management, and psychosocial support on a regular, consistent basis; and 3) determines patient access to CHW support and subspecialty consultations.
Community Health Worker Referral
As a "stepped up" component of the Collaborative Care Team Intervention for patients needing support in overcoming a variety of social determinants
Specialist Care Consultation
As a "stepped up" component of the Collaborative Care Team Intervention for patients with complex medical conditions and/or patients that may not typically have access to specialist care

Locations

Country Name City State
United States Johns Hopkins University School of Medicine Baltimore Maryland

Sponsors (3)

Lead Sponsor Collaborator
Johns Hopkins University National Heart, Lung, and Blood Institute (NHLBI), Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Controlled Blood Pressure Number of participants with Controlled Blood Pressure (<140/90 mm Hg). 12 months
Primary Patient Activation Measure (PAM-13) The Patient Activation Measure assesses knowledge, skills, and confidence in the management of one's health. It is comprised of 13 items and each item is on a 1-5 scale. Insignia health scores on a standardized overall score of 0-100 where higher scores indicate a better outcome. Baseline, 12 months
Secondary Mean Systolic Blood Pressure Mean Systolic Blood Pressure in mm Hg at baseline and 12 months. Baseline, 12 months
Secondary Mean Diastolic Blood Pressure Mean Diastolic Blood Pressure in mm Hg at baseline and 12 months. Baseline, 12 months
Secondary Change in Global Framingham Risk Score Clinical Outcome Baseline, 12, 24 months
Secondary Change in Mean Total Cholesterol (mg/dL) Clinical Outcome Baseline, 12, 24 months
Secondary Change in Mean LDL-C (mg/dL) Clinical Outcome Baseline, 12, 24 months
Secondary Change in Mean HDL (mg/dL) Clinical Outcome Baseline, 12, 24 months
Secondary % With Controlled Total Cholesterol Clinical Outcome Baseline
Secondary % With Controlled Total Cholesterol Clinical Outcome 12 months
Secondary % With Controlled Total Cholesterol Clinical Outcome 24 months
Secondary Change in Mean Glycosylated Hemoglobin (Hemoglobin A1c) Clinical Outcome Baseline, 12, 24 months
Secondary % With Hemoglobin A1c< 7.0 Clinical Outcome Baseline
Secondary % With Hemoglobin A1c< 7.0 Clinical Outcome 12 months
Secondary % With Hemoglobin A1c< 7.0 Clinical Outcome 24 months
Secondary Change in Patient Assessment of Care for Chronic Conditions (PACIC-Plus) Patient Reported Outcome Baseline, 12, 24 months
Secondary % With BP <140/90 mmHg Clinical Outcome 24 months
Secondary % With BP <130/80 mmHg Clinical Outcome 12 months
Secondary % With BP <130/80 mmHg Clinical Outcome 24 months
Secondary % With BP <120/80 mmHg Clinical Outcome 12 months
Secondary % With BP <120/80 mmHg Clinical Outcome 24 months
Secondary Change in Medication Adherence 4-Item Scale Patient Reported Outcome Baseline, 12, 24 months
Secondary Change in Depressive Symptoms Patient Health Questionnaire (PHQ) 8 Score Patient Reported Outcome Baseline 12, 24 months
Secondary Change in Patient Ratings of Trust Patient Reported Outcome Baseline, 12, 24 months
Secondary Change in Hypertension Knowledge and Attitudes Patient Reported Outcome Baseline, 12, 24 months
Secondary Change in Health Related Quality of Life (PROMIS Global Scale) Patient Reported Outcome Baseline, 12, 24 months
Secondary Change in Patient Attainment of Self-Defined Goals Patient Reported Outcome Baseline, 12, 24 months
See also
  Status Clinical Trial Phase
Withdrawn NCT01939392 - Rapid Renal Sympathetic Denervation for Resistant Hypertension II Phase 2/Phase 3
Terminated NCT01966952 - Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension N/A
Completed NCT01699529 - Multi-electrode Radiofrequency Renal Denervation System Feasibility Study N/A
Completed NCT01418261 - SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension N/A
Completed NCT01635998 - Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation N/A
Completed NCT04809519 - Integrative Nursing Based Multimodal Interventions for Uncontrolled Hypertensives N/A
Completed NCT01996033 - EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
Terminated NCT01628198 - Impact of Renal SympAthetic DenerVation on Chronic HypErtension N/A
Recruiting NCT03221114 - Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease N/A
Completed NCT04248530 - DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study N/A
Recruiting NCT06034743 - A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Phase 3
Completed NCT02006758 - Observational Study of the EnligHTN Renal Denervation System in Europe
Active, not recruiting NCT03209154 - An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment N/A
Withdrawn NCT05352425 - Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension N/A
Completed NCT05395403 - Use of Automated Office Blood Pressure Monitoring N/A
Recruiting NCT05732727 - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease Phase 3
Completed NCT02418091 - Integrated Population Program for Diabetic Kidney Disease N/A
Not yet recruiting NCT05234788 - Renal Artery DenervatIon Using Radial accesS in Uncontrolled HyperTensioN N/A
Completed NCT00888433 - Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) N/A
Recruiting NCT05460169 - Renal Denervation in ADPKD- RDN-ADPKD Study N/A